» Articles » PMID: 37736508

Deregulation of Apoptotic Proteins by Induction of (L.f.) Ettingsh Plant Extract in Breast Cancer Cells: A Proteome-wide Analysis

Abstract

Objectives: The present study evaluated the protein-based analysis to unravel the role and mechanism behind the plant extract treatment in breast cancer cells.

Materials And Methods: The protein sample was extracted from the cancer cells after treatment with the plant extract and subjected to two-dimensional electrophoresis for protein separation. Further, the proteins that were differentially regulated among the samples which were treated and non-treated were selected and processed further for protein identification using a tandem mass spectrometry approach.

Results: Using these strategies, we identified 16 potential candidates which were showing remarkable changes in treated samples. All the candidates were analyzed further for gene ontology analysis, and it was observed that all proteins were involved in multiple pathways pertaining to the carcinogenesis process. Specifically, apoptotic pathway proteins including BAD, BIK, BID, CASP8, MCL1, BCL2, and BAK1 were highly impacted by treatment with plant extract. All these protein hits were further taken for validation experiments using RT PCR analysis.

Conclusion: Initiation of these apoptotic proteins by plant extract treatment in breast cancer cells shows a positive direction toward nature-based alternative medicine.

Citing Articles

Probable Molecular Targeting of Inhibitory Effect of Carvacrol-Loaded Bovine Serum Albumin Nanoparticles on Human Breast Adenocarcinoma Cells.

Khodavandi P, Karami N, Khodavandi A, Alizadeh F, Kokhdan E, Zaheri A Chin J Integr Med. 2024; .

PMID: 39581936 DOI: 10.1007/s11655-024-4122-9.

References
1.
Capello M, Ferri-Borgogno S, Riganti C, Chattaragada M, Principe M, Roux C . Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest. Oncotarget. 2016; 7(5):5598-612. PMC: 4868708. DOI: 10.18632/oncotarget.6798. View

2.
Akgul C, Turner P, White M, Edwards S . Functional analysis of the human MCL-1 gene. Cell Mol Life Sci. 2000; 57(4):684-91. PMC: 11147037. DOI: 10.1007/PL00000728. View

3.
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J . STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2014; 43(Database issue):D447-52. PMC: 4383874. DOI: 10.1093/nar/gku1003. View

4.
Campbell K, Dhayade S, Ferrari N, Sims A, Johnson E, Mason S . MCL-1 is a prognostic indicator and drug target in breast cancer. Cell Death Dis. 2018; 9(2):19. PMC: 5833338. DOI: 10.1038/s41419-017-0035-2. View

5.
Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View